GlucoTrack, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 4.44 million compared to USD 4.07 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to USD 0.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | -1.43% | -3.70% | +59.08% |
1st Jan change | Capi. | |
---|---|---|
+59.08% | 11.4M | |
+48.67% | 56.69B | |
-2.76% | 41B | |
+38.45% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |
- Stock Market
- Equities
- GCTK Stock
- News GlucoTrack, Inc.
- GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022